金吾财讯 | 生物医药股继续调整,同源康医药-B(02410)跌24.63%,翰森制药(03692)跌7.52%,科伦博泰生物-B(06990)跌5.18%,康方生物(09926)跌5.17%,乐普生物-B(02157)跌5.10%,诺诚健华(09969)跌4.83%,绿叶制药(02186)跌4.77%,博安生物(06955)跌4.48%,康诺亚-B(02162)跌4.21%。中泰国际表示,随着香港金管局持续回收港元流动性,当前一个月HIBOR回升至2.57%的两个月高位,港美利差快速收窄至1.76%,沽港元买美元的套息交易平仓,导致港汇快速转强。港元资金成本上升直接影响企业融资及投资者的保证金借贷成本,或导致投资者使用杠杆的意欲下降。对于流动性较敏感的生物医药、未有盈利的科技股、本地地产股将面临借势调整压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.